Patents by Inventor Erik Andersen

Erik Andersen has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20230265408
    Abstract: The present invention relates to protease variants, polynucleotides encoding said variants, nucleic acid constructs and expression vectors comprising said polynucleotides, host cells expressing said variants, methods of obtaining the variants, detergent compositions comprising said variants, and use of said variants or said detergent compositions.
    Type: Application
    Filed: August 30, 2021
    Publication date: August 24, 2023
    Applicant: Novozymes A/S
    Inventors: Rolf Thomas Lenhard, Esben Peter Friis, Poul Erik Pedersen, Rasmus Lund Andersen
  • Patent number: 11676251
    Abstract: Method and system for extracting metadata from an observed scene comprising the use of high-speed image sensor array observing the scene through a field-of-view, filtering, matching of interesting information defined as activity/incident in the observed scene with a predefined-library, adapting the filtering to enhance frequencies of interest and suppress all others, and extracting metadata of interest.
    Type: Grant
    Filed: February 3, 2020
    Date of Patent: June 13, 2023
    Inventors: Terje N. Andersen, Bernt Erik Røst
  • Publication number: 20220339096
    Abstract: The present invention relates to methods and compositions for the delivery of cosmetics and medicants. In some embodiments, the invention relates to compositions comprising both hydrophobic and hydrophilic polymers. In preferred embodiments, the invention relates to the delivery of peptides, small molecules and other bioactive compounds using the compositions and methods disclosed herein.
    Type: Application
    Filed: May 9, 2022
    Publication date: October 27, 2022
    Inventors: Nevenka Golubovic-Liakopoulos, Bhavdeep Shah, Erik Andersen
  • Patent number: 11161397
    Abstract: A system for reducing strain on a vehicle door comprises the vehicle door. The vehicle door comprises an inner panel and a division bar comprising a first portion and a second portion. The system further comprises a relief bracket configured to reduce strain on the inner panel when the vehicle door is closed. The relief bracket comprises a first portion coupled to the second portion of the division bar, a second portion coupled to the inner panel, and a relief portion extending between the first portion and the second portion.
    Type: Grant
    Filed: July 30, 2019
    Date of Patent: November 2, 2021
    Assignee: TOYOTA MOTOR ENGINEERING & MANUFACTURING NORTH AMERICA, INC.
    Inventors: Blaine C. Benson, Keith O'Brien, Alyssa J. Flowers-Bouman, Erik Andersen, Wasim Ukra
  • Publication number: 20210268521
    Abstract: A centrifugal separator for industrial separation of a liquid-gas mixture, including a centrifugal separator body having a centrifugal separator body wall, the centrifugal separator body including a cylindrical section and a conical section, a gas outlet positioned at the top end of the centrifugal separator body and a liquid outlet positioned at the bottom end of the centrifugal separator body, the centrifugal separator body further including a liquid-gas mixture inlet orifice, positioned in the cylindrical section of the centrifugal separator body, and a detector for detecting the thickness of the liquid on the centrifugal separator body wall, wherein the detector is positioned in the cylindrical section. A method for monitoring the flow through such a centrifugal separator.
    Type: Application
    Filed: September 5, 2019
    Publication date: September 2, 2021
    Inventors: Jakub BUJALSKI, Stine KARLSEN, Lars-Erik ANDERSEN
  • Publication number: 20210031600
    Abstract: A system for reducing strain on a vehicle door comprises the vehicle door. The vehicle door comprises an inner panel and a division bar comprising a first portion and a second portion. The system further comprises a relief bracket configured to reduce strain on the inner panel when the vehicle door is closed. The relief bracket comprises a first portion coupled to the second portion of the division bar, a second portion coupled to the inner panel, and a relief portion extending between the first portion and the second portion.
    Type: Application
    Filed: July 30, 2019
    Publication date: February 4, 2021
    Inventors: Blaine C. Benson, Keith O'Brien, Alyssa J. Flowers-Bouman, Erik Andersen, Wasim Ukra
  • Publication number: 20180271777
    Abstract: The present invention relates to methods and compositions for the delivery of cosmetics and medicants. In some embodiments, the invention relates to compositions comprising both hydrophobic and hydrophilic polymers. In preferred embodiments, the invention relates to the delivery of peptides, small molecules and other bioactive compounds using the compositions and methods disclosed herein.
    Type: Application
    Filed: March 22, 2018
    Publication date: September 27, 2018
    Inventors: Nevenka Golubovic-Liakopoulos, Bhavdeep Shah, Erik Andersen
  • Patent number: 9949921
    Abstract: The present invention relates to methods and compositions for the delivery of cosmetics and medicants. In some embodiments, the invention relates to compositions comprising both hydrophobic and hydrophilic polymers. In preferred embodiments, the invention relates to the delivery of peptides, small molecules and other bioactive compounds using the compositions and methods disclosed herein.
    Type: Grant
    Filed: January 11, 2016
    Date of Patent: April 24, 2018
    Assignee: Agigma, Inc.
    Inventors: Nevenka Golubovic-Liakopoulos, Bhavdeep Shah, Erik Andersen
  • Patent number: 9703546
    Abstract: Interaction between development environments and runtime environments to ensure that underlying process components are in an acceptable state before deploying application updates. A deploy state monitor in a development environment interacts with runtime values in executing applications to manage deployment requests and states of executing applications.
    Type: Grant
    Filed: December 21, 2015
    Date of Patent: July 11, 2017
    Assignee: Schneider Electric Software, LLC
    Inventors: Scott William Clark, Niels Erik Andersen
  • Publication number: 20170177322
    Abstract: Interaction between development environments and runtime environments to ensure that underlying process components are in an acceptable state before deploying application updates. A deploy state monitor in a development environment interacts with runtime values in executing applications to manage deployment requests and states of executing applications.
    Type: Application
    Filed: December 21, 2015
    Publication date: June 22, 2017
    Applicant: Invensys Systems, Inc.
    Inventors: Scott William Clark, Niels Erik Andersen
  • Publication number: 20170000726
    Abstract: The present invention relates to methods and compositions for the delivery of cosmetics and medicants. In some embodiments, the invention relates to compositions comprising both hydrophobic and hydrophilic polymers. In preferred embodiments, the invention relates to the delivery of peptides, small molecules and other bioactive compounds using the compositions and methods disclosed herein.
    Type: Application
    Filed: January 11, 2016
    Publication date: January 5, 2017
    Inventors: Nevenka Golubovic-Liakopoulos, Bhavdeep Shah, Erik Andersen
  • Patent number: 9233080
    Abstract: The present invention relates to methods and compositions for the delivery of cosmetics and medicants. In some embodiments, the invention relates to compositions comprising both hydrophobic and hydrophilic polymers. In preferred embodiments, the invention relates to the delivery of peptides, small molecules and other bioactive compounds using the compositions and methods disclosed herein.
    Type: Grant
    Filed: March 26, 2009
    Date of Patent: January 12, 2016
    Assignee: Agigma, Inc.
    Inventors: Nevenka Golubovic-Liakopoulos, Bhavdeep Shah, Erik Andersen
  • Patent number: 8846677
    Abstract: Novel compounds which interact with the histamine H3 receptor are defined. These compounds are particularly useful in the treatment of a variety of diseases or conditions in which histamine H3 interactions are beneficial. Thus, the compounds may find use, e.g., in the treatment of diseases of the central nervous system, the peripheral nervous system, the cardiovascular system, the pulmonary system, the gastrointestinal system and the endocrinological system. The novel compounds have a core consisting of a 6 membered aromatic ring containing at least one nitrogen atom and two carbon atoms in the ring and, at the remaining positions in the ring, there is either a carbon or a nitrogen atom.
    Type: Grant
    Filed: May 15, 2012
    Date of Patent: September 30, 2014
    Assignee: High Point Pharmaceuticals, LLC
    Inventors: Rolf Hohlweg, Knud Erik Andersen, Jan Lindy Sorensen, Jane Marie Lundbeck
  • Patent number: 8501739
    Abstract: Novel compounds which interact with the histamine H3 receptor are defined. These compounds are particularly useful in the treatment of a variety of diseases or conditions in which histamine H3 interactions are beneficial. Thus, the compounds may find use, e.g., in the treatment of diseases of the central nervous system, the peripheral nervous system, the cardiovascular system, the pulmonary system, the gastrointestinal system and the endocrinological system. The novel compounds have a core consisting of a 6 membered aromatic ring containing at least one nitrogen atom and two carbon atoms in the ring and, at the remaining positions in the ring, there is either a carbon or a nitrogen atom.
    Type: Grant
    Filed: June 30, 2006
    Date of Patent: August 6, 2013
    Assignee: High Point Pharmaceuticals, LLC
    Inventors: Rolf Hohlweg, Knud Erik Andersen, Jan Lindy Sorensen, Jane Marie Lundbeck
  • Publication number: 20130079340
    Abstract: Certain novel benzothiazoles and benzoxazoles, e.g., 2-(piperazin-1-yl)benzothiazoles and 2-(piperazin-1-yl)benzoxazoles, optionally substituted in the 3 and/or 4 positions of the piperazine rings, having histamine H3 antagonistic activity can be used in pharmaceutical compositions.
    Type: Application
    Filed: October 25, 2012
    Publication date: March 28, 2013
    Inventors: Florencio Zaragoza Dorwald, Rolf Hohlweg, Inge Thoger Christensen, Jane Marie Lundbeck, Knud Erik Andersen
  • Patent number: 8394842
    Abstract: Certain novel benzothiazoles and benzoxazoles, e.g., 2-(piperazin-1-yl)benzothiazoles and 2-(piperazin-1-yl)benzoxazoles, optionally substituted in the 3 and/or 4 positions of the piperazine rings,! of the general formula (1): having histamine H3 antagonistic activity can be used in pharmaceutical compositions.
    Type: Grant
    Filed: March 22, 2007
    Date of Patent: March 12, 2013
    Assignee: High Point Pharmaceuticals, LLC
    Inventors: Florencio Zaragoza Dorwald, Rolf Hohlweg, Inge Thoger Christensen, Jane Marie Lundbeck, Knud Erik Andersen
  • Patent number: 8392706
    Abstract: A method and system for searching and collecting electronically stored information are described. Consistent with an embodiment of the invention, configuration and execution of a search are separated in time and location. For example, a search configuration application executing at a first computer system is utilized to generate a search configuration file, which controls the operation of a search agent when the search agent is executing at a target computer system and performing a search of storage devices act of the target computer system. Encryption is utilized to prevent unauthorized access to the search configuration file as well as the search results file generated by the search agent.
    Type: Grant
    Filed: November 25, 2009
    Date of Patent: March 5, 2013
    Assignee: Perlustro, L.P.
    Inventors: Elliot Spencer, Samuel J. Baker, Erik Andersen
  • Publication number: 20120232078
    Abstract: Novel compounds which interact with the histamine H3 receptor are defined. These compounds are particularly useful in the treatment of a variety of diseases or conditions in which histamine H3 interactions are beneficial. Thus, the compounds may find use, e.g., in the treatment of diseases of the central nervous system, the peripheral nervous system, the cardiovascular system, the pulmonary system, the gastrointestinal system and the endocrinological system. The novel compounds have a core consisting of a 6 membered aromatic ring containing at least one nitrogen atom and two carbon atoms in the ring and, at the remaining positions in the ring, there is either a carbon or a nitrogen atom.
    Type: Application
    Filed: May 15, 2012
    Publication date: September 13, 2012
    Applicant: HIGH POINT PHARMACEUTICALS, LLC
    Inventors: Rolf Hohlweg, Knud Erik Andersen, Jan Lindy Sorensen, Jane Marie Lundbeck
  • Patent number: 8257427
    Abstract: An expandable stent comprising a tubular body made up of a plurality of separated tubular elements (1) arranged along a common longitudinal axis. Each tubular element (1) comprises a plurality of rhombic-shaped closed cell elements (2) joined by circumferentially extending linking members (3). The closed cell elements (2) are expandable to allow the tubular elements, and hence the stent itself, to expand. In the direction of the longitudinal axis of the stent, the extremities of each of the closed cell elements has an enlarged loop (30) with waisted portions (33) which allow the tubular elements to interlock to create a stable structure, at least when in the unexpanded condition.
    Type: Grant
    Filed: June 10, 2009
    Date of Patent: September 4, 2012
    Assignee: J.W. Medical Systems, Ltd.
    Inventors: Erik Andersen, Ning Wen
  • Patent number: 8177609
    Abstract: An apparatus for processing crustaceans comprising a feeder for feeding crustaceans to a singulating and conveying device, said singulating and conveying device delivering the crustaceans individually to at least one separating device, said at least one separating device separating the tail section of each crustacean from the head section thereof.
    Type: Grant
    Filed: November 10, 2009
    Date of Patent: May 15, 2012
    Assignee: Albus Solutions Limited
    Inventor: Erik Andersen